Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 17-Nov-20 3:42 PM View:  | Piekos Brian Chief Financial Officer | AMAG Pharmaceuticals, Inc. (AMAG) | 16-Nov-20 | Disposition | 31,538 | -- | -- | (100%) 31.54K to 0 | |
| 17-Nov-20 3:43 PM View: | O'Brien Kathrine Director | AMAG Pharmaceuticals, Inc. (AMAG) | 16-Nov-20 | Disposition | 18,949 | -- | -- | (100%) 18.95K to 0 | |
| 17-Nov-20 3:41 PM View: | Fallon John A. Director | AMAG Pharmaceuticals, Inc. (AMAG) | 16-Nov-20 | Disposition | 37,362 | -- | -- | (100%) 37.36K to 0 | |
| 17-Nov-20 3:47 PM View: | Johnson David Edward Director 10% Owner | AMAG Pharmaceuticals, Inc. (AMAG) | 16-Nov-20 | Disposition Duplicate | 3,499,430 | -- | -- | (100%) 3.5M to 0 | |
| 17-Nov-20 3:43 PM View: | Santini Gino Director | AMAG Pharmaceuticals, Inc. (AMAG) | 16-Nov-20 | Disposition | 41,473 | -- | -- | (100%) 41.47K to 0 | |
| 17-Nov-20 3:40 PM View: | Casciano Anthony Chief Operating Officer | AMAG Pharmaceuticals, Inc. (AMAG) | 16-Nov-20 | Disposition | 76,349 | -- | -- | (100%) 76.35K to 0 | |
| 17-Nov-20 3:44 PM View: | Vittiglio Joseph Chief Business Officer, GC | AMAG Pharmaceuticals, Inc. (AMAG) | 16-Nov-20 | Disposition | 92,244 | -- | -- | (100%) 92.24K to 0 | |
| 17-Nov-20 3:47 PM View: | Phillips Anne M. Director | AMAG Pharmaceuticals, Inc. (AMAG) | 16-Nov-20 | Disposition | 18,949 | -- | -- | (100%) 18.95K to 0 | |
| 17-Nov-20 3:45 PM View: | Sulat James R Director | AMAG Pharmaceuticals, Inc. (AMAG) | 16-Nov-20 | Disposition | 35,090 | -- | -- | (100%) 35.09K to 0 | |
| 17-Nov-20 3:46 PM View: | Caligan Partners Lp 10% Owner | AMAG Pharmaceuticals, Inc. (AMAG) | 16-Nov-20 | Disposition | 3,499,430 | -- | -- | (100%) 3.5M to 0 | |
| 17-Nov-20 3:40 PM View: | Fonteyne Paul R. Director | AMAG Pharmaceuticals, Inc. (AMAG) | 16-Nov-20 | Disposition | 14,676 | -- | -- | (100%) 14.68K to 0 | |
| 17-Nov-20 3:48 PM View: | Scoon Davey Director | AMAG Pharmaceuticals, Inc. (AMAG) | 16-Nov-20 | Disposition | 43,898 | -- | -- | (100%) 43.9K to 0 | |
| 17-Nov-20 3:47 PM View: | Johnson David Edward Director 10% Owner | AMAG Pharmaceuticals, Inc. (AMAG) | 16-Nov-20 | Disposition | 14,676 | -- | -- | (< 1%) 3.51M to 3.5M | |
| 17-Nov-20 3:46 PM View: | Schick Kelly Chief Human Resources Officer | AMAG Pharmaceuticals, Inc. (AMAG) | 16-Nov-20 | Disposition | 28,155 | -- | -- | (100%) 28.16K to 0 | |
| 05-Oct-20 11:21 AM View: | Camber Capital Management LLC 10% Owner | AMAG Pharmaceuticals, Inc. (AMAG) | 01-Oct-20 | Private Sale | 4,390,000 | $13.57 | $59,586,800.00 | (100%) 4.39M to 0 | |
| 09-Sep-20 4:48 PM View: | Casciano Anthony Chief Operating Officer | AMAG Pharmaceuticals, Inc. (AMAG) | 04-Sep-20 | Payment of Exercise | 392 | $10.10 | $3,959.20 | (< 1%) 76.74K to 76.35K | |
| 04-Jun-20 4:50 PM View: | Phillips Anne M. Director | AMAG Pharmaceuticals, Inc. (AMAG) | 02-Jun-20 | Grant | 10,269 | -- | -- | 118% 8.68K to 18.95K | |
| 04-Jun-20 4:49 PM View: | Sulat James R Director | AMAG Pharmaceuticals, Inc. (AMAG) | 02-Jun-20 | Grant | 10,269 | -- | -- | 41% 24.82K to 35.09K | |
| 04-Jun-20 4:49 PM View: | Fonteyne Paul R. Director | AMAG Pharmaceuticals, Inc. (AMAG) | 02-Jun-20 | Grant | 10,269 | -- | -- | 233% 4.41K to 14.68K | |
| 04-Jun-20 4:48 PM View: | Scoon Davey Director | AMAG Pharmaceuticals, Inc. (AMAG) | 02-Jun-20 | Grant | 10,269 | -- | -- | 31% 33.63K to 43.9K | |
| 04-Jun-20 5:25 PM View: | Johnson David Edward Director 10% Owner | AMAG Pharmaceuticals, Inc. (AMAG) | 02-Jun-20 | Grant | 10,269 | -- | -- | < 1% 3.5M to 3.51M | |
| 04-Jun-20 4:48 PM View: | O'Brien Kathrine Director | AMAG Pharmaceuticals, Inc. (AMAG) | 02-Jun-20 | Grant | 10,269 | -- | -- | 118% 8.68K to 18.95K | |
| 04-Jun-20 4:49 PM View: | Fallon John A. Director | AMAG Pharmaceuticals, Inc. (AMAG) | 02-Jun-20 | Grant | 10,269 | -- | -- | 38% 27.09K to 37.36K | |
| 04-Jun-20 4:50 PM View: | Santini Gino Director | AMAG Pharmaceuticals, Inc. (AMAG) | 02-Jun-20 | Grant | 10,269 | -- | -- | 33% 31.2K to 41.47K | |
| 06-Apr-20 8:26 PM View: | Casciano Anthony Chief Commercial Officer | AMAG Pharmaceuticals, Inc. (AMAG) | 04-Apr-20 | Payment of Exercise | 1,468 | $6.14 | $9,013.52 | (2%) 78.21K to 76.74K | |
| 06-Apr-20 8:26 PM View: | Schick Kelly Chief Human Resources Officer | AMAG Pharmaceuticals, Inc. (AMAG) | 02-Apr-20 | Payment of Exercise | 79 | $6.18 | $488.22 | (< 1%) 28.23K to 28.16K | |
| 18-Mar-20 4:52 PM View: | Armistice Capital, LLC 10% Owner | AMAG Pharmaceuticals, Inc. (AMAG) | 16-Mar-20 | Private Purchase | 24,000 | $4.87 | $116,880.00 | < 1% 4.44M to 4.47M | |
| 12-Mar-20 4:11 PM View: | Schick Kelly Chief Human Resources Officer | AMAG Pharmaceuticals, Inc. (AMAG) | 10-Mar-20 | Grant | 13,000 | -- | -- | 85% 15.23K to 28.23K | |
| 12-Mar-20 4:11 PM View: | Vittiglio Joseph CBO, General Counsel | AMAG Pharmaceuticals, Inc. (AMAG) | 10-Mar-20 | Grant | 25,000 | -- | -- | 37% 67.24K to 92.24K | |
| 12-Mar-20 4:11 PM View: | Casciano Anthony Chief Commercial Officer | AMAG Pharmaceuticals, Inc. (AMAG) | 10-Mar-20 | Grant | 25,000 | -- | -- | 47% 53.21K to 78.21K | |
| 12-Mar-20 4:12 PM View: | Myles Edward H COO & CFO | AMAG Pharmaceuticals, Inc. (AMAG) | 10-Mar-20 | Grant | 30,000 | -- | -- | 44% 68.66K to 98.66K | |
| 04-Mar-20 5:50 PM View: | Heiden William K President & CEO Director | AMAG Pharmaceuticals, Inc. (AMAG) | 02-Mar-20 | Payment of Exercise | 4,451 | $7.75 | $34,495.20 | (1%) 429.06K to 424.61K | |
| 04-Mar-20 5:50 PM View: | Casciano Anthony Chief Commercial Officer | AMAG Pharmaceuticals, Inc. (AMAG) | 02-Mar-20 | Payment of Exercise | 924 | $7.75 | $7,161.00 | (2%) 54.13K to 53.21K | |
| 04-Mar-20 5:49 PM View: | Vittiglio Joseph CBO, General Counsel | AMAG Pharmaceuticals, Inc. (AMAG) | 02-Mar-20 | Payment of Exercise | 1,138 | $7.75 | $8,819.50 | (2%) 68.38K to 67.24K | |
| 04-Mar-20 5:48 PM View: | Krop Julie Chief Medical Officer | AMAG Pharmaceuticals, Inc. (AMAG) | 02-Mar-20 | Payment of Exercise | 1,333 | $7.75 | $10,330.80 | (2%) 74.38K to 73.04K | |
| 04-Mar-20 5:50 PM View: | Schick Kelly Chief Human Resources Officer | AMAG Pharmaceuticals, Inc. (AMAG) | 02-Mar-20 | Payment of Exercise | 358 | $7.75 | $2,774.50 | (2%) 15.59K to 15.23K | |
| 04-Mar-20 5:49 PM View: | Myles Edward H COO & CFO | AMAG Pharmaceuticals, Inc. (AMAG) | 02-Mar-20 | Payment of Exercise | 1,021 | $7.75 | $7,912.75 | (1%) 69.68K to 68.66K | |
| 25-Feb-20 4:48 PM View: | Casciano Anthony Chief Commercial Officer | AMAG Pharmaceuticals, Inc. (AMAG) | 25-Feb-20 | Payment of Exercise | 881 | $8.84 | $7,788.04 | (1%) 59.01K to 58.13K | (5%) |
| 25-Feb-20 4:43 PM View: | Vittiglio Joseph CBO, General Counsel | AMAG Pharmaceuticals, Inc. (AMAG) | 25-Feb-20 | Payment of Exercise | 2,206 | $8.84 | $19,501.00 | (3%) 78.09K to 75.88K | (5%) |
| 25-Feb-20 4:46 PM View: | Krop Julie Chief Medical Officer | AMAG Pharmaceuticals, Inc. (AMAG) | 25-Feb-20 | Payment of Exercise | 1,155 | $8.84 | $10,210.20 | (1%) 83.03K to 81.88K | (5%) |
| 27-Feb-20 5:27 PM View: | Armistice Capital, LLC 10% Owner | AMAG Pharmaceuticals, Inc. (AMAG) | 25-Feb-20 | Private Purchase | 36,000 | $8.29 | $298,440.00 | < 1% 4.41M to 4.44M | |
| 25-Feb-20 4:44 PM View: | Schick Kelly Chief Human Resources Officer | AMAG Pharmaceuticals, Inc. (AMAG) | 25-Feb-20 | Payment of Exercise | 1,095 | $8.84 | $9,679.80 | (7%) 16.69K to 15.59K | (5%) |
| 25-Feb-20 4:49 PM View: | Myles Edward H COO & CFO | AMAG Pharmaceuticals, Inc. (AMAG) | 25-Feb-20 | Payment of Exercise | 1,386 | $8.84 | $12,252.20 | (2%) 78.57K to 77.18K | (5%) |
| 25-Feb-20 4:50 PM View: | Heiden William K President & CEO Director | AMAG Pharmaceuticals, Inc. (AMAG) | 25-Feb-20 | Payment of Exercise | 3,033 | $8.84 | $26,811.70 | (< 1%) 487.1K to 484.06K | (5%) |
| 25-Feb-20 4:44 PM View: | Schick Kelly Chief Human Resources Officer | AMAG Pharmaceuticals, Inc. (AMAG) | 23-Feb-20 | Payment of Exercise | 463 | $9.50 | $4,398.50 | (3%) 17.15K to 16.69K | 2% |
| 25-Feb-20 4:49 PM View: | Myles Edward H COO & CFO | AMAG Pharmaceuticals, Inc. (AMAG) | 23-Feb-20 | Payment of Exercise | 867 | $9.50 | $8,236.50 | (1%) 79.43K to 78.57K | 2% |
| 25-Feb-20 4:50 PM View: | Heiden William K President & CEO Director | AMAG Pharmaceuticals, Inc. (AMAG) | 23-Feb-20 | Payment of Exercise | 2,960 | $9.50 | $28,120.00 | (< 1%) 490.06K to 487.1K | 2% |
| 25-Feb-20 4:48 PM View: | Casciano Anthony Chief Commercial Officer | AMAG Pharmaceuticals, Inc. (AMAG) | 23-Feb-20 | Payment of Exercise | 463 | $9.50 | $4,398.50 | (< 1%) 59.48K to 59.01K | 2% |
| 25-Feb-20 4:43 PM View: | Vittiglio Joseph CBO, General Counsel | AMAG Pharmaceuticals, Inc. (AMAG) | 23-Feb-20 | Payment of Exercise | 867 | $9.50 | $8,236.50 | (1%) 78.95K to 78.09K | 2% |
| 25-Feb-20 4:46 PM View: | Krop Julie Chief Medical Officer | AMAG Pharmaceuticals, Inc. (AMAG) | 23-Feb-20 | Payment of Exercise | 867 | $9.50 | $8,236.50 | (1%) 83.9K to 83.03K | 2% |
